214 related articles for article (PubMed ID: 23312225)
1. Biomarkers of ovarian response: current and future applications.
Nelson SM
Fertil Steril; 2013 Mar; 99(4):963-9. PubMed ID: 23312225
[TBL] [Abstract][Full Text] [Related]
2. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
[TBL] [Abstract][Full Text] [Related]
4. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
5. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
La Marca A; Sunkara SK
Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
[TBL] [Abstract][Full Text] [Related]
6. Ovarian response biomarkers: physiology and performance.
Iliodromiti S; Nelson SM
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):182-6. PubMed ID: 25919234
[TBL] [Abstract][Full Text] [Related]
7. Possibilities and limits of ovarian reserve testing in ART.
La Marca A; Argento C; Sighinolfi G; Grisendi V; Carbone M; D'Ippolito G; Artenisio AC; Stabile G; Volpe A
Curr Pharm Biotechnol; 2012 Mar; 13(3):398-408. PubMed ID: 21657996
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.
La Marca A; Sighinolfi G; Argento C; Grisendi V; Casarini L; Volpe A; Simoni M
Fertil Steril; 2013 Mar; 99(4):970-8.e1. PubMed ID: 23380184
[TBL] [Abstract][Full Text] [Related]
9. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
[TBL] [Abstract][Full Text] [Related]
10. Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers.
Grisendi V; La Marca A
Minerva Ginecol; 2017 Jun; 69(3):250-258. PubMed ID: 28271699
[TBL] [Abstract][Full Text] [Related]
11. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen.
Freour T; Masson D; Dessolle L; Allaoua D; Dejoie T; Mirallie S; Jean M; Barriere P
Arch Gynecol Obstet; 2012 Apr; 285(4):1177-82. PubMed ID: 22183426
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
McIlveen M; Skull JD; Ledger WL
Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
[TBL] [Abstract][Full Text] [Related]
13. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.
La Marca A; Papaleo E; Grisendi V; Argento C; Giulini S; Volpe A
BJOG; 2012 Sep; 119(10):1171-9. PubMed ID: 22805536
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
15. The antral follicle count: practical recommendations for better standardization.
Broekmans FJ; de Ziegler D; Howles CM; Gougeon A; Trew G; Olivennes F
Fertil Steril; 2010 Aug; 94(3):1044-51. PubMed ID: 19589513
[TBL] [Abstract][Full Text] [Related]
16. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
[TBL] [Abstract][Full Text] [Related]
17. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
[TBL] [Abstract][Full Text] [Related]
18. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.
Lekamge DN; Lane M; Gilchrist RB; Tremellen KP
J Assist Reprod Genet; 2008; 25(11-12):515-21. PubMed ID: 18972201
[TBL] [Abstract][Full Text] [Related]
19. [Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer].
Chen SL; Xia R; Chen X; Luo YQ; Wang LL; Wu YQ; Shi XY; Zheng HY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):572-7. PubMed ID: 21515446
[TBL] [Abstract][Full Text] [Related]
20. Ovarian aging: latest thoughts on assessment and management.
Younis JS
Curr Opin Obstet Gynecol; 2011 Dec; 23(6):427-34. PubMed ID: 21897233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]